10.1016/j.joca.2021.06.013 5 BensaA.AlbaneseJ.BoffaA.PrevitaliD.FilardoG
For more information, please visit Forward-Looking Statements Statements contained in this press release regarding matters that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended
Instead of jumping quickly to higher doses, microdosing GLP-1 medications generally involves starting with smaller amounts or moving more gradually over time
UnitedHealthcare covers certain GLP-1 receptor agonists, but approval depends on specific plan design, clinical criteria, and whether medications are prescribed for diabetes or weight management
S.SunL.RustgiS.TangY.Von WettsteinD.MysoreK
Weve always treated it that way, but I think the medical field has had trouble truly seeing it as a chronic disease